CACLP

14/07/2026

Industry | In Vitro Diagnostic Industry in China - III––

At present, the new combining scheme of urinalysis workflow consisting of dedicated urine-specific protein analyzer and biochemical analyzer has been launched.

In addition to urine routine analysis and urine formed element analysis, it can also quantitatively analyze specific proteins, enzymes and other chemical components in urine, realizing one-stop detection of multiple dimensions and multi-methods of clinicopathological urine specimens, providing accurate, timely and rich diagnostic information for clinical practice.

For more information 🔗 https://en.caclp.com/industry-news/3981.html

13/07/2026

Business | China's Industry Highlights

🤝 Maccura✖️HUAWEI Partner on Smart Laboratory Development
🤝 Sansure✖️Qingfeng Kerui Form Strategic Partnership
🌍 Liferiver’s Ebola Test Kit Added to WHO Emergency Use List
🏅 Hotgen✖️Peking University Joint Laboratory Approved as Beijing Key Laboratory
📈 NanoMicro Forecasts Strong Growth for First Half of 2026

For detail 👉 https://en.caclp.com/industry-news/3979.html

10/07/2026

Event | 📊 by the Numbers

🏢 1,208 exhibitors from across the global IVD value chain gathered in Xiamen this March.

🌏 The vast majority of exhibitors represented China’s dynamic industry, while a growing international presence highlighted the increasing global influence of the Chinese IVD market and the expanding opportunities for cross-border collaboration.

📩 Stay informed with the latest CACLP news https://en.caclp.com/subscribe.html

💬 Interested in exhibiting or partnering with us? Contact us via [email protected]

09/07/2026

VIEW | 🔬 How can we see deeper into biological tissues without sacrificing molecular detail?

A new review highlights the remarkable progress achieved by combining optical clearing with fluorescence imaging. By reducing light scattering within tissues, optical clearing techniques are enabling high-resolution visualization of structures far beyond the reach of conventional fluorescence imaging, opening new possibilities for cancer diagnostics, pathology, and biomedical research.

For full research 👉🏻 https://onlinelibrary.wiley.com/doi/epdf/10.1002/viw2.70178

📚 From VIEW, an open access journal for interdisciplinary research focused on “biodiagnostics” in the field of biomaterials.

08/07/2026

Go Global Webinar | 🌍 Connecting China with the Community

This session on July 2nd successfully brought together industry experts to explore one of the most important topics for Chinese IVD companies: expanding into the European market under the EU IVDR framework.

The webinar featured insightful discussions on:
✅ Why the EU is a strategic first step for global market expansion
✅ Key IVDR requirements and market access pathways
✅ Integrating regulatory planning into product development from Day 1
✅ Practical strategies for building long-term global competitiveness

As China's IVD industry continues to accelerate its internationalization, CACLP remains committed to serving as a bridge between domestic innovation and global opportunities.

Follow CACLP or subscribe to CACLP Newsletter https://en.caclp.com/subscribe.html for more updates!

07/07/2026

Industry | In Vitro Diagnostic Industry in China - II––––

According to the technical principles, the urine formed element analyzers are mainly divided into static digital imaging shooting technology, flow digital image imaging technology, and flow nucleic acid fluorescence staining technology.

At present, the main brands of urine formed element analyzers in China's market use flow digital imaging shooting technology or static digital imaging shooting technology.

For more information 🔗 https://en.caclp.com/industry-news/3972.html

06/07/2026

Business | China industry highlights this week

🧪 Cytiva Localizes Production of Automated Industrial Chromatography Columns in China
🤝 YHLO Biotech Hosts Vietnamese Laboratory Experts to Advance International Diagnostics Collaboration
🏥 Maccura and Zhifang Technology Partner to Advance Smart Laboratory Solutions
🩸 DIRUI Medical and Aimagine Care Technology Join Forces to Expand Smart Hematology Solutions Globally
🧬 Shanghai BioScience Co., Ltd. and Geneus Technologies Partner to Expand Single-Molecule Sequencing

For more information 👉 https://en.caclp.com/industry-news/3970.html

03/07/2026

Webinar Replay | Understanding the Key Characteristics of China’s Compliance Pathway for Overseas Companies📋

China remains one of the world's most attractive IVD markets—but successful market entry starts with understanding its regulatory framework.

In this replay, Jieyan Diao, IVD Expert in Regulatory Affairs at Beijing Tigermed-Jyton Co., Ltd., breaks down the key compliance considerations for overseas IVD manufacturers, including registration requirements, regulatory updates, common challenges, and practical guidance for navigating China's evolving market access pathway.

Whether you're planning to enter the China market or optimize your regulatory strategy, this session offers valuable insights to help you move forward with confidence.

🎥 Watch the replay clip https://youtu.be/CNN2dYhQDxA?si=kIjVXNUf1FgW-DKI

▶️ Register to watch the full webinar replay https://en.caclp.com/webinar-enquiry.html?before=17&fileid=1

This session shared insights into registration requirements, regula...

02/07/2026

VIEW | 🦠 Can improve outcomes in hospitalized patients?

A new multicenter real-world study analyzed data from 12,615 hospitalized patients infected with the Omicron variant across 10 hospitals. The findings suggest that probiotic supplementation was associated with a 27% reduction in all-cause mortality, with the greatest benefits observed in patients with severe disease and those not receiving antiviral therapy.

The study also found probiotics to be generally well tolerated, providing important real-world evidence for microbiome-based supportive strategies against respiratory viral infections.

For full research 👉🏻 https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20250074

📚 From VIEW, an open access journal for interdisciplinary research focused on “biodiagnostics” in the field of biomaterials.

02/07/2026

Webinar Replay | Understanding China’s Business Environment for Overseas Companies ⭐️

How can overseas IVD companies succeed in China's evolving diagnostics market?

In this replay, Kevin Meng, BD Director of Annoroad Gene Technology (Beijing) Co., Ltd., shares practical insights into China's changing IVD business environment, from policy and regulatory trends to innovation opportunities and localization strategies.

🎥 Watch the replay clip https://youtu.be/ZjS-dWyPBmg?si=5_IcPJU2YHtnrRwZ

▶️ Register to watch the whole webinar replay https://en.caclp.com/webinar-enquiry.html?before=17&fileid=1

📄 Register to download the slides https://en.caclp.com/webinar-resources.html?before=17&fileid=2

This session shares insights on policy trends, innovation pathways,...